AGP Picks
View all

Technology News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.

Press releases published on October 25, 2026

New Book “Discern the Energy” Offers a Powerful Framework to Break Generational Trauma and Reclaim Personal Light
PrintSheetLab Adds Free Math Calculators That Show Every Step
EverNear Develops AI Voice Companion to Support Older Adults Living With Alzheimer's Disease
Powering Up for Those That Show Up – A New Community Initiative Goes Live from Jackery
KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
Sweet Security Research Identifies Go Implementation of Node2Shell Vulnerability, Expanding Attack Surface to Major HTTP Frameworks
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer …
Automating SEO and Link Building for AI Agents with Rapid Indexer's New MCP Server1
Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
BioNTech und Bristol Myers Squibb präsentieren ermutigende Daten aus globaler Phase-2-Studie mit Pumitamig bei fortgeschrittenem nicht-kleinzelligem Lungenkrebs nach Progression der Erkrankung unter einer Immuntherapie und Chemotherapie
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
From Trend to Texture: ANECO Brings Four Skincare Trends to Life at in-cosmetics Asia 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.